3M Beams Into Clinical Diagnostics With Acolyte Biomedica Acquisition
This article was originally published in The Gray Sheet
Executive Summary
3M entered the clinical diagnostics market Feb. 14 with its acquisition of U.K.-based Acolyte Biomedica and the BacLite system for detecting hospital-associated infectious diseases